“From target to translation - together.”
David Schreib
Chief Commercial Officer
We recognize that the success of our LNP platform is intrinsically linked to the success of our partners. We invite you to connect with us and discuss your specific needs in drug delivery. Our team is prepared to explore a variety of collaboration models, catering to different partnership types. Whether you represent a biotechnology or pharmaceutical company, or a contract service organization, we are eager to explore the potential for cooperation.
Fee-for-service, co-development, or license of Adalid libraries and methods once your delivery challenge is solved. We look forward to talking to you about how we can help you to drive forward innovative solutions in gene delivery.
We understand that everyone’s roles and priorities are different. See how we can align with yours.
Your focus is on clinical success and regulatory confidence.
Our LNP platform is GMP-ready, scalable, and designed for safety—helping you accelerate programs from lab to market.
Innovation drives your mission.
Our flexible, adaptable LNPs enable fast proof-of-concept and support novel therapeutic modalities—so you can move quickly without compromising quality.
Your clients need robust, reliable solutions.
Our LNP technology transfers seamlessly to manufacturing, with reproducible processes that help you deliver value and differentiation.
Your research shapes the future.
We provide accessible formulations and scientific collaboration to empower discovery in RNA therapeutics and gene editing.
You help clients navigate complex choices.
Our proven, safe, and regulatory-aligned LNP platform offers the reliability and expertise you can confidently recommend.Our approach is founded on a robust product, the first-class expertise of our scientific teams, and our commitment to seamlessly integrating into your workflow.
Pharma
Your focus is on clinical success and regulatory confidence.
Our LNP platform is GMP-ready, scalable, and designed for safety—helping you accelerate programs from lab to market.
Biotech
Innovation drives your mission.
Our flexible, adaptable LNPs enable fast proof-of-concept and support novel therapeutic modalities—so you can move quickly without compromising quality.
CDMO / CRO
Your clients need robust, reliable solutions.
Our LNP technology transfers seamlessly to manufacturing, with reproducible processes that help you deliver value and differentiation.
Academia
Your research shapes the future.
We provide accessible formulations and scientific collaboration to empower discovery in RNA therapeutics and gene editing.
Consultancy
You help clients navigate complex choices.
Our proven, safe, and regulatory-aligned LNP platform offers the reliability and expertise you can confidently recommend.Our approach is founded on a robust product, the first-class expertise of our scientific teams, and our commitment to seamlessly integrating into your workflow.
We are ready to support our partners from discovery to commercialization.
You can rely on fair and predictable path towards commercialization with client driven approach with flexible approach on collaboration parameters including the target selection and pricing structure.
01
Initial Conversation
We’ll be happy to introduce our technology and listen to your needs and expectations. A CDA will allow a more detailed exchange of information.
02
Technology Evaulation
We are ready to assist your team in a cost-free evaluation of our delivery platform with the payload of your choice.
03
Term Sheet
The key parameters of our collaborationin using our technology in your development pipeline.
04
Development & Option Agreement
We will work together with you to make sure that your clinical candidate is using the optional LNP formulation.
05
License Agreement
A framework to enable clinical development and commercialization of your product using our LNP technology
Joint Work Plan development: target cell/tissue, route, payload (mRNA/siRNA/mcDNA/editors), indication & success criteria.
Experimental and data plan, assays, and comparators aligned up front.
Using a semi-automated high-throughput LNP assembly pipeline, we generate structure-performance maps.
Modular libraries: ionizable lipids, helper lipids/sterols, and click-ready polymer–lipid stabilizers for ligand attachment (antibodies, nanobodies, peptides).
Rapid in-vitro screening → down-selection by potency, selectivity, viability, and innate-signal profile.
In-vivo biodistribution and potency, safety readouts.
Tech transfer to your CDMO or ours: analytics, specs, and scale-up support toward IND-enablement.
Program design
Joint Work Plan development: target cell/tissue, route, payload (mRNA/siRNA/mcDNA/editors), indication & success criteria.
Experimental and data plan, assays, and comparators aligned up front.
Data-driven lead creation
Using a semi-automated high-throughput LNP assembly pipeline, we generate structure-performance maps.
Modular libraries: ionizable lipids, helper lipids/sterols, and click-ready polymer–lipid stabilizers for ligand attachment (antibodies, nanobodies, peptides).
Rapid in-vitro screening → down-selection by potency, selectivity, viability, and innate-signal profile.
Preclinical translation & transfer
In-vivo biodistribution and potency, safety readouts.
Tech transfer to your CDMO or ours: analytics, specs, and scale-up support toward IND-enablement.
Post transfer support
Lorem ipsum
Lorem ipsum
Engagement options:
fee-for-service, co-development, or license of Adalid libraries and methods once your delivery challenge is solved.
We look forward to talking to you about how we can help you to drive forward innovative solutions in gene delivery.
Next-generation lipid nanoparticles for gene delivery.
Billing information
Adalid Sciences, s.r.o.
Podbabska 2582/30
160 00, Praha 6
Czech Republic
Reg. No 21691053
VAT No CZ21691053
